Product Information

CHOLESTYRAMINE LIGHT POWDER is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1621 per GM under NDC 68382052942. Its NADAC has been published 419 times since Jul 18, 2018.

FDA first approved this application on Apr 25, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CHOLESTYRAMINE LIGHT POWDER

CHOLESTYRAMINE
$0.1621per GM

Strength

4 g/5.5g

NDC

68382052942

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CHOLESTYRAMINE

Approval Type

Generic (ANDA)

FDA Application

ANDA202902

FDA Approved

4/25/2017

TE Code

AB

On Market Since

6/8/2017

Pharmacological Classes

Bile Acid Sequestrant
Bile-acid Binding Activity

Price Statistics

The NADAC for CHOLESTYRAMINE LIGHT POWDER has been published 419 times since Jul 18, 2018, and over the history we have for it it has declined 29.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1621 per GM
All-time high$0.2595 (Aug 14, 2019)
All-time low$0.1343 (Nov 20, 2024)
52-week high$0.1704
52-week low$0.1471
Median price$0.1994
Average price$0.1972
Largest weekly change+42.1% (Sep 23, 2020)
Weeks tracked419
Tracking sinceJul 18, 2018

Price History

1W

+6.9%

1M

+6.9%

3M

+4.5%

6M

-3.6%

1Y

+6.3%

3Y

-5.5%

5Y

-23.6%

All

-29.9%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 42% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 42%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of CHOLESTYRAMINE LIGHT POWDER?

The current National Average Drug Acquisition Cost (NADAC) for CHOLESTYRAMINE LIGHT POWDER, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1621 per GM (NDC 68382052942), effective Aug 19, 2026.

How has the price of CHOLESTYRAMINE LIGHT POWDER changed over time?

Over the history we have for it, the NADAC for CHOLESTYRAMINE LIGHT POWDER has declined 29.9%. It has been tracked across 419 weekly CMS publications since Jul 18, 2018.

What are the highest and lowest recorded NADAC prices for CHOLESTYRAMINE LIGHT POWDER?

Since Jul 18, 2018, the NADAC for CHOLESTYRAMINE LIGHT POWDER has ranged from a low of $0.1343 (Nov 20, 2024) to a high of $0.2595 (Aug 14, 2019), with a median of $0.1994 per GM.

Are there cheaper alternatives to CHOLESTYRAMINE LIGHT POWDER?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHOLESTYRAMINE POWDER, is $0.0946 per GM — about 42% below CHOLESTYRAMINE LIGHT POWDER.

Who manufactures CHOLESTYRAMINE LIGHT POWDER?

CHOLESTYRAMINE LIGHT POWDER (NDC 68382052942) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.